Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
Open accessThe DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index.
Abstract
Significance: Beta-amyloid plaque accumulation, glucose hypometabolism, and neuronal atrophy are hallmarks of Alzheimer’s disease. However, the regional ordering of these biomarkers prior to dementia remains untested. In a cohort with Alzheimer’s disease mutations, we performed an integrated whole-brain analysis of three major imaging techniques: amyloid PET, [ 18 F]fluro-deoxyglucose PET, and structural MRI. We found that most gray-matter structures with amyloid plaques later have hypometabolism followed by atrophy. Critically, however, not all regions lose metabolic function, and not all regions atrophy, even when there is significant amyloid deposition. These regional disparities have important implications for clinical trials of disease-modifying therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that progression of biomarker measures is also a continuous process that begins before symptoms [9–14]”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [10]
In the citing paper
“The first biomarkers to become abnormal in carriers of deterministic AD mutations are those of Aβ [9–11,14].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [10]
In the citing paper
“Nevertheless, neuroimaging and biomarker studies show consistencies in the sequential onset of amyloid deposition, tau, FDG-PET hypometabolism, grey matter atrophy, and clinical presentation between late-onset and autosomal-dominant Alzheimer’s disease (Bateman et al., 2012; Benzinger et al., 2013; Young et al., 2014; Gordon et al., 2018; Oxtoby et al., 2018), suggesting substantial commonalities”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Benzinger et al., 2013
In the citing paper
“Since the precuneus region has been shown to be most sensitive to Alzheimer’s disease pathophysiology in autosomal-dominant Alzheimer’s disease2,24, we focused our analyses on this region a priori.”
From Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) · cites this paper as [24]
In the citing paper
“ADAD work has revealed a temporal ordering of biomarkers consistent with theoretical models,6–8 and indications that pathology progressively appears in new regions of the brain as the disease worsens7.”
From Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study (2018) · cites this paper as [7]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Our results are also consistent with the neuropathological studies that have found differential temporal ordering of the formation of amyloid plaques and neurofibrillary tangles (25, 26).”
Resultggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324 · cited 1×
“Each voxel in the brain was assigned an anatomical label (53, 79).”
MethodA default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190 · cited 2×
“As previously reported (18), the most commonly affected areas across modalities bear a striking resemblance to the default mode network (20) Furthermore, studies in LOAD have found spreading patterns of atrophy (21, 22), hypometabolism (23), and amyloid deposition (24) as a correlate of increasing disease severity.”
BackgroundSelf-citationRobust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594 · cited 1×
“To estimate the trajectory of biomarker changes, curves were fit to the cross-sectional data using LOESS regression (91).”
Methodnlme : Linear and nonlinear mixed effects models
DebRoy, S. (2006) · Medical Entomology and Zoology · Cited by 10,009
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationFischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.021 · Cited by 9,526
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 5×
“Perani D, Grassi F, Sorbi S (1997) PET study in subjects from two Italian FAD families with APP717 Val to Ileu mutation.”
BackgroundInfluentialMeasuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,818 · cited 1×
“For each vertex on the cortical surface, thickness was calculated as the shortest distance from the gray/white boundary to the gray/CSF boundary (81).”
MethodThresholding of statistical maps in functional neuroimaging using the false discovery rate
Genovese, C. R., Lazar, N. A., & Nichols, T. (2002) · NeuroImage · doi:10.1006/nimg.2001.1037 · Cited by 4,923 · cited 7×
“01 after correction for multiple comparisons across the brain using a false discovery rate (FDR) (13) of 0.”
MethodInfluentialHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 3×
“analysis of [11C]PIB brain scans? Neuroimage 60(3):1716–1723.”
BackgroundInfluentialSelf-citationGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 5×
“Perani D, Grassi F, Sorbi S (1997) PET study in subjects from two Italian FAD families with APP717 Val to Ileu mutation.”
BackgroundInfluentialSelf-citationSmall sample inference for fixed effects from restricted maximum likelihood
Kenward, M. G., & Roger, J. H. (1997) · Biometrics · doi:10.2307/2533558 · Cited by 4,552 · cited 2×
“Kenward MG, Roger JH (1997) Small sample inference for fixed effects from restricted maximum likelihood.”
MethodJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationThe Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347 · cited 1×
“Structural MRI acquisition was performed using the Alzheimer’s Disease Neuroimaging Initiative (ADNI) protocol (76, 77).”
MethodSelf-citationCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 3×
“Cruchaga C, et al.; NIA-LOAD/NCRAD Family Study Consortium (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s disease families.”
BackgroundClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citationCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 2×
“Cruchaga C, et al.; NIA-LOAD/NCRAD Family Study Consortium (2012) Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer’s disease families.”
BackgroundVillemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Self-citationBuckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · cited 2×
“As previously reported (18), the most commonly affected areas across modalities bear a striking resemblance to the default mode network (20) Furthermore, studies in LOAD have found spreading patterns of atrophy (21, 22), hypometabolism (23), and amyloid deposition (24) as a correlate of increasing disease severity.”
BackgroundResultSelf-citationA Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098 · cited 3×
“T pathological mechanisms underlying nondominantly inherited late onset Alzheimer’s disease (LOAD) remain an active area of investigation (1).”
BackgroundInfluentialThinning of the Cerebral Cortex in Aging
Salat, D. H. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh032 · Cited by 1,851
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Self-citationMultimodal classification of Alzheimer's disease and mild cognitive impairment
Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.008 · Cited by 1,314
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · cited 1×
“Alternatively, this association has been understood as reflecting the fact that metabolism and Aβ deposition both are driven by neuronal activity (30).”
BackgroundSelf-citationDynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132 · cited 1×
“As previously reported (18), the most commonly affected areas across modalities bear a striking resemblance to the default mode network (20) Furthermore, studies in LOAD have found spreading patterns of atrophy (21, 22), hypometabolism (23), and amyloid deposition (24) as a correlate of increasing disease severity.”
BackgroundSelf-citationLINEAR AND NONLINEAR MIXED-EFFECTS MODELS
Bates, D. M., & Pinheiro, J. C. (1998) · Conference on Applied Statistics in Agriculture · doi:10.4148/2475-7772.1273 · Cited by 1,033
Zhou, J., Greicius, M. D., Gennatas, E. D., Growdon, M. E., Jang, J. Y., Rabinovici, G. D., Kramer, J. H., Weiner, M., Miller, B. L., & Seeley, W. W. (2010) · Brain · doi:10.1093/brain/awq075 · Cited by 1,016 · cited 1×
“In support of this hypothesis, recent studies using resting-state functional MRI have reported an increase in functional connectivity between the ACC and other nodes of the salience network (46, 47).”
ResultSelf-citationFunctional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · cited 1×
“Previous studies in presymptomatic AD typically have reported decreased glucose metabolism (27).”
BackgroundCorrection for partial volume effects in PET: principle and validation.
ROUSSET, O. G., Ma, Y., & Evans, A. C. (1998) · PubMed · Cited by 919
Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785 · cited 1×
“In contrast, autosomal dominant AD (ADAD) caused by mutations in the APP (7), presenilin 1 (PSEN1) (8), and presenilin 2 (PSEN2) (9) genes has virtually complete penetrance with a predictable age of onset (4).”
BackgroundRaz, N., Gunning-Dixon, F., Head, D., Rodrigue, K. M., Williamson, A., & Acker, J. D. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00118-0 · Cited by 714 · cited 1×
“Similarly, studies using voxel-based morphometry (44) and manual segmentation (45) have found a preservation of the anterior cingulate in normal aging.”
ResultHigh Consistency of Regional Cortical Thinning in Aging across Multiple Samples
Fjell, A. M., Westlye, L. T., Amlien, I., Espeseth, T., Reinvang, I., Raz, N., Agartz, I., Salat, D. H., Greve, D. N., Fischl, B., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn232 · Cited by 695
Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., & Rossor, M. N. (1996) · Brain · doi:10.1093/brain/119.6.2001 · Cited by 656
Self-citationMayavi: 3D Visualization of Scientific Data
Ramachandran, P., & Varoquaux, G. (2011) · Computing in Science & Engineering · doi:10.1109/mcse.2011.35 · Cited by 648
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607 · cited 1×
“As previously reported (18), the most commonly affected areas across modalities bear a striking resemblance to the default mode network (20) Furthermore, studies in LOAD have found spreading patterns of atrophy (21, 22), hypometabolism (23), and amyloid deposition (24) as a correlate of increasing disease severity.”
BackgroundSelf-citationBrier, M. R., Thomas, J. B., Snyder, A. Z., Benzinger, T. L., Zhang, D., Raichle, M. E., Holtzman, D. M., Morris, J. C., & Ances, B. M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5698-11.2012 · Cited by 595 · cited 1×
“In support of this hypothesis, recent studies using resting-state functional MRI have reported an increase in functional connectivity between the ACC and other nodes of the salience network (46, 47).”
ResultSelf-citationJack, C. R., Twomey, C. K., Zinsmeister, A. R., Sharbrough, F. W., Petersen, R. C., & Cascino, G. D. (1989) · Radiology · doi:10.1148/radiology.172.2.2748838 · Cited by 592 · cited 1×
“Segmented volumes were corrected for intracranial volume using an analysis of covariance approach (80).”
MethodSelf-citationReiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A. M., Shah, A. R., Alvarez, S., Arbelaez, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70228-4 · Cited by 541 · cited 1×
“Future study of even younger individuals with ADAD mutations clearly is needed to determine whether or not this abnormality truly precedes fibrillar Aβ deposition (31).”
BackgroundSelf-citationMechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab
Ostrowitzki, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1538 · Cited by 431 · cited 1×
“Published trials of antiamyloid treatments have already used global measures of amyloid deposition as a primary outcome measure (69).”
BackgroundSelf-citationBrain β-amyloid load approaches a plateau
Jack, C. R., Wiste, H. J., Lesnick, T. G., Weigand, S. D., Knopman, D. S., Vemuri, P., Pankratz, V. S., Senjem, M. L., Gunter, J. L., Mielke, M. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840bbe · Cited by 406
Self-citationHinrichs, C., Singh, V., Xu, G., & Johnson, S. C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.081 · Cited by 405
Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389 · cited 13×
“Similarly, our finding of increased PiB in occipital cortex is not typical of LOAD (17).”
BackgroundInfluentialSelf-citationUpdate on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative
Jack, C. R., Bernstein, M. A., Borowski, B. J., Gunter, J. L., Fox, N. C., Thompson, P. M., Schuff, N., Krueger, G., Killiany, R. J., DeCarli, C. S., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.004 · Cited by 378
Self-citationLa Joie, R., Perrotin, A., Barré, L., Hommet, C., Mézenge, F., Ibazizene, M., Camus, V., Abbas, A., Landeau, B., Guilloteau, D., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2170-12.2012 · Cited by 374 · cited 1×
“The regional variability of biomarker trajectories found in this report is consistent with previous neuroimaging results that have identified distinct spatial patterns of amyloid accumulation, hypometabolism, and atrophy (18), where biomarker effects vary across brain regions (19).”
ResultThe Dynamics of Cortical and Hippocampal Atrophy in Alzheimer Disease
Sabuncu, M. R. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.167 · Cited by 339
Self-citationTracking atrophy progression in familial Alzheimer's disease: a serial MRI study
Ridha, B. H., Barnes, J., Bartlett, J. W., Godbolt, A., Pepple, T., Rossor, M. N., & Fox, N. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70550-6 · Cited by 326
Self-citationCruchaga, C., Chakraverty, S., Mayo, K., Vallania, F. L. M., Mitra, R. D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031039 · Cited by 320
Self-citationAccelerating Cortical Thinning: Unique to Dementia or Universal in Aging?
Fjell, A. M., Westlye, L. T., Grydeland, H., Amlien, I., Espeseth, T., Reinvang, I., Raz, N., Dale, A. M., Walhovd, K. B., & Initiative, F. T. A. D. N. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs379 · Cited by 305
Salat, D. H., Lee, S. Y., van der Kouwe, A. J., Greve, D. N., Fischl, B., & Rosas, H. D. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.074 · Cited by 293 · cited 1×
“Previous studies have reported alterations in image contrast properties in both aging (39) and AD (40).”
Background(2006) · PubMed · Cited by 269
Acosta-Baena, N., Sepulveda-Falla, D., Lopera-Gómez, C. M., Jaramillo-Elorza, M. C., Moreno, S., Aguirre-Acevedo, D. C., Saldarriaga, A., & Lopera, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70323-9 · Cited by 263 · cited 2×
“Within early-onset ADAD families, the parental age of onset tends to be conserved between family members (5, 6, 10).”
BackgroundVillain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255
Self-citationMinoshima, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199507000-00006 · Cited by 252 · cited 8×
“However, there have been reports in normal aging (28) and mild cognitive impairment (29) of an association between early PiB uptake and hypermetabolism, albeit of variable focality, as determined by FDG PET.”
BackgroundInfluentialReducing between scanner differences in multi-center PET studies
Joshi, A., Koeppe, R. A., & Fessler, J. A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.057 · Cited by 247 · cited 1×
“Differences owing to image resolution across scanners were minimized by smoothing PET images to a common resolution of 8 mm isotropic (84).”
BackgroundSelf-citationFleisher, A. S., Chen, K., Quiroz, Y. T., Jakimovich, L. J., Gomez, M. G., Langois, C. M., Langbaum, J. B., Ayutyanont, N., Roontiva, A., Thiyyagura, P., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70227-2 · Cited by 242 · cited 1×
“This is consistent with a recent cross-sectional report in another large ADAD cohort (14).”
ResultCohen, A. D., Price, J. C., Weissfeld, L. A., James, J., Rosario, B. L., Bi, W., Nebes, R. D., Saxton, J. A., Snitz, B. E., Aizenstein, H. A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3669-09.2009 · Cited by 240 · cited 2×
“However, there have been reports in normal aging (28) and mild cognitive impairment (29) of an association between early PiB uptake and hypermetabolism, albeit of variable focality, as determined by FDG PET.”
BackgroundSelf-citationAging in the CNS: Comparison of gray/white matter volume and diffusion tensor data
Abe, O., Yamasue, H., Aoki, S., Suga, M., Yamada, H., Kasai, K., Masutani, Y., Kato, N., Kato, N., & Ohtomo, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.003 · Cited by 238 · cited 1×
“Similarly, studies using voxel-based morphometry (44) and manual segmentation (45) have found a preservation of the anterior cingulate in normal aging.”
ResultIncreased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers
Potter, R., Patterson, B. W., Elbert, D. L., Ovod, V., Kasten, T., Sigurdson, W., Mawuenyega, K., Blazey, T., Goate, A., Chott, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005615 · Cited by 236
Self-citationMorris, J. C., Aisen, P. S., Bateman, R. J., Benzinger, T. L., Cairns, N. J., Fagan, A. M., Ghetti, B., Goate, A. M., Holtzman, D. M., Klunk, W. E., et al. (2012) · Clinical Investigation · doi:10.4155/cli.12.93 · Cited by 208 · cited 2×
“The Dominantly Inherited Alzheimer Network (DIAN) has established a large cohort of individuals from families with ADADmutations (11).”
BackgroundSelf-citationBoosting power for clinical trials using classifiers based on multiple biomarkers
Kohannim, O., Hua, X., Hibar, D. P., Lee, S., Chou, Y.-Y., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.022 · Cited by 190
Self-citationMann, D. M. A., Pickering-Brown, S. M., Takeuchi, A., & Iwatsubo, T. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64688-3 · Cited by 182
Villemagne, V. L., Ataka, S., Mizuno, T., Brooks, W. S., Wada, Y., Kondo, M., Jones, G., Watanabe, Y., Mulligan, R., Nakagawa, M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.285 · Cited by 174
Self-citationAssessing the onset of structural change in familial Alzheimer's disease
Schott, J. M., Fox, N. C., Frost, C., Scahill, R. I., Janssen, J. C., Chan, D., Jenkins, R., & Rossor, M. N. (2003) · Annals of Neurology · doi:10.1002/ana.10424 · Cited by 163
Self-citationFrouin, V., Comtat, C., Reilhac, A., & Grégoire, M. (2002) · PubMed · Cited by 149
Caroli, A., & Frisoni, G. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.024 · Cited by 148
Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers
Fortea, J., Sala‐Llonch, R., Bartrés‐Faz, D., Bosch, B., Lladó, A., Bargalló, N., Molinuevo, J. L., & Sánchez‐Valle, R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100678 · Cited by 147
Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
Jack, C. R., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Lowe, V., Kantarci, K., Bernstein, M. A., Senjem, M. L., Gunter, J. L., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3405 · Cited by 145
Self-citationKoivunen, J., Verkkoniemi, A., Aalto, S., Paetau, A. E., Ahonen, J.-P., Viitanen, M. H., Någren, K., Rokka, J., Haaparanta‐Solin, M., Kalimo, H., et al. (2008) · Brain · doi:10.1093/brain/awn107 · Cited by 125 · cited 14×
“Similarly, our finding of increased PiB in occipital cortex is not typical of LOAD (17).”
BackgroundInfluentialFörster, S., Grimmer, T., Miederer, I., Henriksen, G., Yousefi, B. H., Graner, P., Wester, H.-J., Förstl, H., Kurz, A., Dickerson, B. C., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.023 · Cited by 119 · cited 1×
“As previously reported (18), the most commonly affected areas across modalities bear a striking resemblance to the default mode network (20) Furthermore, studies in LOAD have found spreading patterns of atrophy (21, 22), hypometabolism (23), and amyloid deposition (24) as a correlate of increasing disease severity.”
BackgroundRegistration of [18F]FDG microPET and small-animal MRI
Rowland, D. J., Garbow, J. R., Laforest, R. A., & Snyder, A. Z. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.05.002 · Cited by 109 · cited 1×
“Each participant’s PET data were motion-corrected and registered to his or her MRI (82, 83).”
MethodSelf-citationZaidi, H., Ruest, T., Schoenahl, F., & Montandon, M.-L. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.05.031 · Cited by 108 · cited 1×
“Although this method has been reported to be accurate (48), it is biased from misregistrations between the PET and MRI data (49) and by inaccurate segmentation of the MRI data (50).”
MethodOh, H., Habeck, C., Madison, C., & Jagust, W. (2014) · Human Brain Mapping · doi:10.1002/hbm.22173 · Cited by 101 · cited 1×
“However, there have been reports in normal aging (28) and mild cognitive impairment (29) of an association between early PiB uptake and hypermetabolism, albeit of variable focality, as determined by FDG PET.”
BackgroundFamilial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway
Lippa, C. F., Saunders, A. M., Smith, T. W., Swearer, J. M., Drachman, D. A., Ghetti, B., Nee, L., Pulaski-Salo, D., Dickson, D., Robitaille, Y., et al. (1996) · Neurology · doi:10.1212/wnl.46.2.406 · Cited by 97
Self-citationFox, N. (1997) · Brain · doi:10.1093/brain/120.3.491 · Cited by 93 · cited 1×
“Within early-onset ADAD families, the parental age of onset tends to be conserved between family members (5, 6, 10).”
BackgroundSelf-citationSalat, D. H., Chen, J. J., van der Kouwe, A. J. W., Greve, D. N., Fischl, B. R., & Rosas, H. D. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.034 · Cited by 91 · cited 1×
“Previous studies have reported alterations in image contrast properties in both aging (39) and AD (40).”
BackgroundChromosome 14 linked familial Alzheimer's disease: A clinico-pathological study of a single pedigree
Kennedy, A. M., Newman, S. K., Frackowiak, R. S. J., Cunningham, V. J., Roques, P., Stevens, J., Neary, D., Bruton, C. J., Warrington, E. K., & Rossor, M. N. (1995) · Brain · doi:10.1093/brain/118.1.185 · Cited by 88
Self-citationKnight, W. D., Okello, A. A., Ryan, N. S., Turkheimer, F. E., Rodríguez Martinez de Llano, S., Edison, P., Douglas, J., Fox, N. C., Brooks, D. J., & Rossor, M. N. (2011) · Brain · doi:10.1093/brain/awq310 · Cited by 84
Self-citationFOX, N. C., WARRINGTON, E. K., STEVENS, J. M., & ROSSOR, M. N. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34423.x · Cited by 61
Self-citationA novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies
Houlden, H., Crook, R., Dolan, R. J., McLaughlin, J., Révész, T., & Hardy, J. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02254-6 · Cited by 55 · cited 1×
“Within early-onset ADAD families, the parental age of onset tends to be conserved between family members (5, 6, 10).”
BackgroundLee, G. J., Lu, P. H., Medina, L. D., Rodriguez-Agudelo, Y., Melchor, S., Coppola, G., Braskie, M. N., Hua, X., Apostolova, L. G., Leow, A. D., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-302087 · Cited by 53 · cited 1×
“In contrast to prior publications (51, 52), we did not detect caudate atrophy in our ADAD cohort.”
ResultSelf-citationDominantly inherited Alzheimer's disease: cerebral glucose metabolism.
Polinsky, R. J., NOBLE, H. M., Chiro, G. D., Nee, L. E., Feldman, R. G., & Brown, R. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.6.752 · Cited by 51
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease
Roe, C. M., Fagan, A. M., Williams, M. M., Ghoshal, N., Aeschleman, M., Grant, E. A., Marcus, D. S., Mintun, M. A., Holtzman, D. M., & Morris, J. C. (2011) · Neurology · doi:10.1212/wnl.0b013e31820af900 · Cited by 50
Self-citationAcceleration of cortical thinning in familial Alzheimer's disease
Knight, W. D., Kim, L. G., Douiri, A., Frost, C., Rossor, M. N., & Fox, N. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.013 · Cited by 47
Self-citationSu, Y., Arbeláez, A. M., Benzinger, T. L. S., Snyder, A. Z., Vlassenko, A. G., Mintun, M. A., & Raichle, M. E. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.143 · Cited by 47 · cited 1×
“We are currently investigating noninvasive, MRI-based methods of obtaining the AIF and quantitative PET data (38).”
MethodSelf-citationCharacterization of extrastriatal D2 in vivo specific binding of [18F](N‐methyl)benperidol using PET
Eisenstein, S. A., Koller, J. M., Piccirillo, M. L., Kim, A., Antenor‐Dorsey, J. A. V., Videen, T. O., Snyder, A. Z., Karimi, M., Moerlein, S. M., BLACK, K. J., et al. (2012) · Synapse · doi:10.1002/syn.21566 · Cited by 43
Self-citationCan target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?
Edison, P., Hinz, R., Ramlackhansingh, A. F., Thomas, J., Gelosa, G., Archer, H. A., Turkheimer, F., & Brooks, D. J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.099 · Cited by 42
Differences in regional brain atrophy in genetic forms of Alzheimer's disease
Gregory, G. C., Macdonald, V., Schofield, P. R., Kril, J. J., & Halliday, G. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.011 · Cited by 37
Self-citationGinestroni, A., Battaglini, M., Nave, R. D., Moretti, M., Tessa, C., Giannelli, M., Caffarra, P., Nacmias, B., Bessi, V., Sorbi, S., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5044-3 · Cited by 36
Cortical and Hippocampal Atrophy in Patients with Autosomal Dominant Familial Alzheimer’s Disease
Apostolova, L. G., Hwang, K. S., Medina, L. D., Green, A. E., Braskie, M. N., Dutton, R. A., Lai, J., Geschwind, D. H., Cummings, J. L., Thompson, P. M., et al. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330471 · Cited by 31
Self-citationPET study in subjects from two Italian FAD families with APP717 Val to Ileu mutation
Perani, D., Grassi, F., Sorbi, S., Nacmias, B., Piacentini, S., Piersanti, P., Provinciali, L., Amaducci, L. A., & Fazio, F. (1997) · European Journal of Neurology · doi:10.1111/j.1468-1331.1997.tb00337.x · Cited by 17
Morphological characteristics of senile plaques in familial Alzheimer's disease
Iseki, E., Matsushita, M., Kosaka, K., Suzuki, K., Amano, N., & Saito, A. (1990) · Acta Neuropathologica · doi:10.1007/bf00294638 · Cited by 13 · cited 1×
“For example, neuropathological examinations of the globus pallidus in ADAD cases have reported findings consistent with amyloid angiopathy (16, 17).”
BackgroundPrice (1999) · doi:10.1002/1531-8249(199903)45:3
Self-citation
Cited by
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationRevised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803
Self-citationBlood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274
Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
“Late application PET imaging allows us to visualize Aβ fibrils in patients, which accumulate in an Alzheimer’s brain as early as 15 years before the onset of symptoms.(477) A change in CSF Aβ levels can be detected even up to 25 years before a patient begins to show symptoms.”
Background
Metadata
- Authors
- Benzinger, T. L. S., Blazey, T., Jack, C. R., Koeppe, R. A., Su, Y., Xiong, C., Raichle, M. E., Snyder, A. Z., Ances, B. M., Bateman, R. J., Cairns, N. J., Fagan, A. M., Goate, A., Marcus, D. S., Aisen, P. S., Christensen, J. J., Ercole, L., Hornbeck, R. C., Farrar, A. M., Aldea, P., Jasielec, M. S., Owen, C. J., Xie, X., Mayeux, R., Brickman, A., McDade, E., Klunk, W., Mathis, C. A., Ringman, J., Thompson, P. M., Ghetti, B., Saykin, A. J., Sperling, R. A., Johnson, K. A., Salloway, S., Correia, S., Schofield, P. R., Masters, C. L., Rowe, C., Villemagne, V. L., Martins, R., Ourselin, S., Rossor, M. N., Fox, N. C., Cash, D. M., Weiner, M. W., Holtzman, D. M., Buckles, V. D., Moulder, K., & Morris, J. C.
- Affiliations
- Washington University in St. Louis (US)
- Departments of aRadiology,
- Mayo Clinic (US)
- University of Michigan (US)
- Biostatistics,
- Neurology,
- Pathology and Immunology, and
- University of California San Diego (US)
- Columbia University Irving Medical Center (US)
- Departments of jNeurology,
- University of Pittsburgh (US)
- Department of Neurology, Easton Center for Alzheimer’s Disease Research and
- University of California, Los Angeles (US)
- Department of Pathology and Laboratory Medicine, and
- Indiana University Indianapolis (US)
- Harvard University (US)
- Brown University (US)
- UNSW Sydney (AU)
- Mental Health Research Institute (AU)
- Austin Hospital (AU)
- Edith Cowan University (AU)
- Dementia Research Centre, Institute of Neurology, University College London, London WC1N 3GB, United Kingdom; and
- UCL Queen Square Institute of Neurology (GB)
- San Francisco VA Medical Center (US)
- ORCID
- Benzinger, Tammie L. S.
- Blazey, Tyler
- Jack, Clifford R.
- Koeppe, Robert A.
- Su, Yi
- Xiong, Chengjie
- Raichle, Marcus E.
- Snyder, Abraham Z.
- Ances, Beau M.
- Bateman, Randall J.
- Fagan, Anne M.
- Goate, Alison
- Marcus, Daniel S.
- Hornbeck, Russ C.
- Mayeux, Richard
- Brickman, Adam
- McDade, Eric
- Klunk, William
- Mathis, Chester A.
- Ringman, John
- Thompson, Paul M.
- Ghetti, Bernardino
- Saykin, Andrew J.
- Sperling, Reisa A.
- Johnson, Keith A.
- Salloway, Stephen
- Correia, Stephen
- Schofield, Peter R.
- Masters, Colin L.
- Rowe, Christopher
- Villemagne, Victor L.
- Martins, Ralph
- Rossor, Martin N.
- Fox, Nick C.
- Cash, David M.
- Weiner, Michael W.
- Holtzman, David M.
- Morris, John C.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-11-05
- Volume
- 110
- Issue
- 47
- Pages
- E4502-9
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3839740
- OpenAlex
- W2053288220
- Cited by
- 391
- References
- 97
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 22 · 2023: 24 · 2022: 21 · 2021: 45 · 2020: 36 · 2019: 19 · 2018: 47 · 2017: 33 · 2016: 32 · 2015: 40 · 2014: 20 · 2013: 1
- FWCI
- 22.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Online (Edith Cowan University) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10033, NF-SI-0508-10123)
- National Institutes of Health (1s10rr022984-01a1, UL1TR000448)
- National Institute on Aging (U19AG032438, U24AG021886)
- National Institute of Nursing Research (R01NR012657)
- National Institute of General Medical Sciences (T32GM008151)
- National Institute of Neurological Disorders and Stroke (P30NS048056)
- National Institute of Biomedical Imaging and Bioengineering (P41EB015922)
- National Center for Research Resources (S10 RR022984, 1S10RR022984-01A1)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- autosomal dominant Alzheimer's disease, imaging biomarkers, amyloid deposition, Pittsburgh compound B PET, FDG-PET, glucose metabolism, cortical thinning, brain atrophy, hypermetabolism, precuneus, posterior cingulate cortex, symptom onset, longitudinal disease progression, mutation carriers
- MeSH terms
- Adult, Alzheimer Disease, Aniline Compounds, Brain, Carbon Radioisotopes, Female, Genes, Dominant, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Models, Biological, Regression Analysis, Thiazoles, Time Factors, Cohort Studies, Biomarkers, Age of Onset, Fluorodeoxyglucose F18, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.